CRP

Cardiac Risk Markers

Heart disease progresses gradually. Cardiac stress or damage triggers molecule release for healing. These markers, normally low, rise with damage severity, serving as indicators for heart issues, aiding prevention, diagnosis, prognosis, and treatment monitoring.

Gemini_Generated_Image_oa0f7doa0f7doa0f

D Dimer

D-dimer is a fibrin degradation product, a biomarker elevated in blood during clot breakdown. In heart disease, high D-dimer levels may indicate thrombosis or cardiovascular events like acute coronary syndrome, aiding in diagnosis and risk assessment.

Gemini_Generated_Image_jqgmojqgmojqgmoj

HbA1c

HbA1c, or glycated hemoglobin, reflects average blood glucose levels over 2–3 months. In heart disease, elevated HbA1c indicates poor glycemic control, increasing cardiovascular risk. It’s used to assess diabetes management and predict heart complications.

Gemini_Generated_Image_k6v958k6v958k6v9

Adenosine Deaminase(ADA)

Adenosine deaminase (ADA) is an enzyme crucial for purine metabolism, converting adenosine to inosine. Its levels can serve as a biomarker for heart disease, particularly in chronic heart failure (CHF), where ADA activity decreases as disease severity increases, potentially aiding in diagnosis and monitoring.

Gemini_Generated_Image_fx7lurfx7lurfx7l

Homocysteine

Homocysteine is an amino acid linked to cardiovascular risk. Elevated levels, often due to vitamin B deficiencies, can damage blood vessels, increasing the risk of heart disease and stroke. It’s used to assess and monitor cardiovascular health.

Gemini_Generated_Image_45msar45msar45ms

Immunoglobulins

Immunoglobulins (IgA, IgG, IgM) are antibodies that may rise in response to inflammation or infection in heart disease. Elevated levels, particularly IgG, can indicate chronic inflammation linked to atherosclerosis, aiding in assessing cardiovascular risk and disease progression.

PCT

PCT

Procalcitonin (PCT) is a biomarker elevated in bacterial infections and inflammation. In heart disease, increased PCT levels may indicate sepsis or acute heart failure complications, aiding in diagnosis, risk stratification, and guiding antibiotic therapy.

Gemini_Generated_Image_ate4bmate4bmate4

C-Reactive Protein Advance

C-reactive protein (CRP), an inflammation marker, rises in heart disease. Kivo CRPAdvance, a high-linearity (0.5–250 mg/L) latex-enhanced turbidimetric assay, reliably detects elevated CRP in bacterial/viral infections, aiding diagnosis and monitoring of cardiovascular and inflammatory conditions.

Gemini_Generated_Image_gbjny8gbjny8gbjn

Ferritin

Ferritin, a protein storing iron, is a biomarker in heart disease. Elevated levels may indicate inflammation or oxidative stress linked to atherosclerosis and heart failure, aiding in risk assessment and monitoring disease progression.

Gemini_Generated_Image_8364dg8364dg8364

Plac Test

The PLAC test measures lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme linked to vascular inflammation and plaque instability. Elevated Lp-PLA2 levels indicate a higher risk of coronary heart disease and stroke, aiding in cardiovascular risk assessment.